Company Overview

Dr. Musella, a retired podiatrist and technologist, is founder and president of The Musella Foundation For Brain Tumor Research & Information, Inc, a 501(c)(3) nonprofit public charity established in 1997 to help brain tumor patients through emotional and financial support, education, advocacy and fundraising for brain tumor research.

In this role, Dr. Musella established the first clinical trial database for brain tumors, upon which the National Cancer Institute modeled Clinicaltrials.gov. Dr. Musella has issued more than $19.3 million in brain tumor research grants and co-payment assistance grants to help patients access needed treatments. He also advocated for FDA and Medicare approval for Optune, Temodar, Gliadel, Gleolan, Avastin and many other treatments. His current efforts include lobbying for the “Promising Pathway Act,” legislation that accelerates the clinical trial approval process in order to move new drugs to market more efficiently.